Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Torrent Pharmaceuticals Ltd. (TORP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,698.45 +4.15    +0.15%
26/04 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE685A01028 
S/N:  TORNTPHARM
  • Volume: 146,641
  • Bid/Ask: 2,687.15 / 2,698.50
  • Day's Range: 2,685.10 - 2,729.20
Torrent Pharma 2,698.45 +4.15 +0.15%

TORP User Rankings

 
Users ranking according to the performance of their sentiments for the Torrent Pharmaceuticals Ltd. stock.
RankUsernameTotalClosedWinningWin %Chg. %
1madhukar bagve111100+36.32%
2Manohar lal Arora111100+13.32%
3bhuvana sekar111100+11.26%
4phani kiran111100+11.06%
5Rohit Giri111100+10.55%
6Sagar Talekar111100+8.93%
7tubi ddiction111100+8.86%
8Gautam Mukherjee111100+8.49%
9Hema Shamnani111100+7.75%
10geerjee kn111100+6.58%
11Angel Touch111100+4.98%
12koushik kumar111100+3.93%
13nitesh dadape111100+3.39%
14Lakshmipriya Du111100+3.25%
15sandeep singh111100+2.98%
16manoj shinde111100+2.88%
17Dhruvil Jain111100+2.85%
18Jago India1000+2.76%
19nilesh mane111100+2.43%
20raghu raghu22150+2.33%
21Dhruv Thakker111100+1.98%
22GIRISH BHOJ111100+1.84%
23harish chhabra111100+1.51%
24Deepesh Kumar1000+1.03%
25Akash Fopale22150+0.69%
26Bhaswati Saha22150+0.47%
27Namdev Panchal111100+0.44%
28Sunil Banka111100+0.09%
29Ramanuja Gangu11000%
30Rushikesh Sinkar11000%
31Archit Vikam2200-0.02%
32Rahul Sarkar1100-0.08%
33Mohammed Hossain Khan1100-0.12%
34mrp mrp1100-0.13%
35Deepika Katiyar1100-0.13%
36Lavanya Goshamahal1100-0.18%
37Pritam Patra1100-0.22%
38Shweta Bhatia1100-0.25%
39Abinash Podh1000-0.44%
40Swapnil Deshmukh1100-0.45%
41Rushikesh Patil1100-0.55%
42raktim ranjan1100-0.71%
43Varun Agarwal1100-0.8%
44abantika biswas1100-1.15%
45Alagesan Alagesan1100-1.62%
46Pankaj Singh1100-1.68%
47jignesh ranpurwala1100-1.71%
48Shubham Veer1100-2.01%
49KOSHRED IN1100-2.25%
50PRATHAMESH BANDEKAR1100-2.29%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TORP Comments

Write your thoughts about Torrent Pharmaceuticals Ltd.
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
invest market
INVEST2MARKETS Sep 20, 2023 12:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Delivery Buy TORNTPHARMA above 1906 Stop Loss 1827 Target 2000+
invest market
INVEST2MARKETS Mar 02, 2023 11:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy TORNTPHARM Above 1507 Stop Loss 1439 Targets 1560-1590
invest market
INVEST2MARKETS Mar 02, 2023 11:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Torntpharma Revised Stop Loss 1535 from 1480 (Profit +28, Even if Rev.SL Hit)
bhanwar kandoi
bhanwar kandoi May 25, 2022 11:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow see a jump of 200+ points??
bhanwar kandoi
bhanwar kandoi May 25, 2022 11:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow see a jump of 200+ points??
bhanwar kandoi
bhanwar kandoi May 25, 2022 11:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow see a jump of 200+ points??
Samir Pal
Samir Pal Mar 21, 2022 4:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Rightly identified the dcc pattern and today it started it downward journey.
raibareli branch
raibareli branch Dec 18, 2021 5:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bill side
Umesh Goswami
Umesh Goswami Jul 13, 2021 5:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy INFIBEAM at 49 to 50 target 70++
Rakesh Vishwakarma
Rakesh Vishwakarma Apr 26, 2021 11:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Engineertrading:
Rakesh Vishwakarma
Rakesh Vishwakarma Apr 26, 2021 11:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Engineertrading:
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email